These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Risk for definite neuroleptic malignant syndrome. A prospective study in 223 consecutive in-patients. Hermesh H, Aizenberg D, Weizman A, Lapidot M, Mayor C, Munitz H. Br J Psychiatry; 1992 Aug 01; 161():254-7. PubMed ID: 1355693 [Abstract] [Full Text] [Related]
10. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome. Lee JW. Ann Clin Psychiatry; 2007 Aug 01; 19(1):9-16. PubMed ID: 17453656 [Abstract] [Full Text] [Related]
13. A fulminant case of neuroleptic malignant syndrome. Teo SK, Lam KN, Chew WL. Singapore Med J; 1994 Feb 01; 35(1):110-1. PubMed ID: 8009269 [Abstract] [Full Text] [Related]
14. Death due to fulminant neuroleptic malignant syndrome induced by low doses of haloperidol: a rare case. Zou D, Shao Y, Qin Z, Zhang J, Liu N, Li Z, Huang P, Chen Y. J Forensic Leg Med; 2014 May 01; 24():12-4. PubMed ID: 24794843 [Abstract] [Full Text] [Related]
15. [Neuroleptic malignant syndrome]. Charra B, Nejmi H, Hachimi A, Benslama A, Motaouakkil S. Ann Fr Anesth Reanim; 2006 May 01; 25(5):542-3. PubMed ID: 16488105 [No Abstract] [Full Text] [Related]
19. Neuroleptic-induced catatonia as a stage in the progression toward neuroleptic malignant syndrome. Woodbury MM, Woodbury MA. J Am Acad Child Adolesc Psychiatry; 1992 Nov 01; 31(6):1161-4. PubMed ID: 1429421 [Abstract] [Full Text] [Related]